Reduced IL-4-, lipopolysaccharide-, and IFN-γ-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain

Journal of Immunology

Volumn 163, Issue 5, 1999, Pages 2425-2431

  Itoh Lindstrom, Yoshie ^a,b,c   Piskurich, Janet F ^a   Felix, Nathan J ^b   Wang, Ying ^a   Brickey, W June ^a   Platt, Jeffrey L ^c   Koller, Beverly H ^b   Ting, Jenny P Y ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GENE DELETION; KNOCKOUT MOUSE; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; THYMUS;

ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MEMBRANE; CROSSES, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; GTP-BINDING PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IGG DEFICIENCY; IMMUNOGLOBULIN M; INTERFERON TYPE II; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; SEQUENCE DELETION; TRANS-ACTIVATORS; UP-REGULATION;

EID: 0033198138     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Cresswell, P. 1996. Invariant chain structure and MHC class II function. Cell 84:505.
2. Fling, S. P., B. Arp, and D. Pious. 1994. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368:554.
3. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82:155.
4. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457.
5. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001.
6. Weber, D. A., B. D. Evavold, and P. E. Jensen. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274:618.
7. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, and L. Van Kaer. 1996. H2-mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84:543.
8. Ting, J. P.-Y., and A. S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8.
9. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Anna. Rev. Immunol. 14:301.
10. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
11. Chin, K.-C., C. Mao, C. Skinner, J. L. Riley, K. L. Wright, C. S. Moreno, G. R. Stark, J. M. Boss, and J. P.-Y. Ting. 1994. Molecular analysis of GIB and G3A IFN γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1:687.
12. Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106.
13. Chang, C. H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
14. Chang, C. H., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181: 765.
15. Kern, I., V. Steimle, C. A. Siegrist, and B. Mach. 1995. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int. Immunol. 7:1295.
16. Ting, J. P.-Y., K. L. Wright, K.-C. Chin, W. J. Brickey, and G. Li. 1997. The DMB promoter: delineation, in vivo footprint, trans-activation, and trans-dominant suppression. J. Immunol. 159:5457.
17. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533.
18. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
19. Chin, K.-C., G. X. Li, and J. P.-Y. Ting. 1997. Importance of acidic, proline/ serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. USA 94:2501.
20. Wright, K. L., K.-C. Chin, M. Linhoff, C. Skinner, J. A. Brown, J. M. Boss, G. R. Stark, and J. P.-Y. Ting. 1998. CIITA stimulation of transcription factor binding to MHC class II and associated promoters in vivo. Proc. Natl. Acad. Sci. USA 95:6267.
21. Hahn, S. 1993. Structure(?) and function of acidic transcription activators. Cell 72:481.
22. Radtke, F., O. Georgiev, H. P. Muller, E. Brugnera, and W. Schaffner. 1995. Functional domains of the heavy metal-responsive transcription regulator MTF-1. Nucleic Acids Res. 23:2277.
23. Bassel-Duby, R., M. D. Hernandez, Q. Yang, J. M. Rochelle, M. F. Seldin, and R. S. Williams. 1994. Myocyte nuclear factor, a novel winged-helix transcription factor under both developmental and neural regulation in striated myocytes. Mol. Cell. Biol. 14:4596.
24. Xiao, H., A. Pearson, B. Coulombe, R. Truant, S. Zhang, J. L. Regier, S. J. Triezenberg, D. Reinberg, O. Flores, C. J. Ingles, et al. 1994. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14:7013.
25. Kim, T. K., and R. G. Roeder. 1994. Proline-rich activator CTF1 targets the TFIIB assembly step during transcriptional activation. Proc. Natl. Acad. Sci. USA 91:4170.
26. Williams, G. S., M. Malin, D. Vremec, C. H. Chang, R. Boyd, C. Benoist, and D. Mathis. 1998. Mice lacking the transcription factor CIITA: a second look. Int. Immunol. 10:1957.
27. Tybulewicz, V. L. J., C. E. Crawford, P. K. Jackson, R. T. Bronson, and R. C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65:1153.
28. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
29. Finkelman, F. D., K. B. Madden, S. C. Morris, J. M. Holmes, N. Boiani, I. M. Katona, and C. R. Maliszewski. 1993. Anti-cytokine antibodies as carrier proteins: prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anticytokine antibody complexes. J. Immunol. 151:1235.
30. Cosgrove, D., D. Grey, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051.
31. Grusby, M. J., and L. H. Glimcher. 1995. Immune responses in MHC class II-deficient mice. Annu. Rev. Immunol. 13:417.
32. Chang, C.-H., S. Guerder, S.-C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167.
33. Stuart, P. M., A. Zlotnik, and J. G. Woodward. 1988. Induction of class I and class II MHC antigen expression on murine bone marrow-derived macrophages by IL-4 (B cell stimulatory factor 1). J. Immunol. 140:1542.
34. Muhlethaler-Mottet, A., W. Di Berardino, L. A. Otten, and B. Mach. 1998. Activation of the MHC class II transactivator CIITA by interferon γ requires cooperative interaction between Stal1 and USF-1. Immunity 8:157.
35. Piskurich, J. F., Y. Wang, M. W. Linhoff, L. C. White, and J. P. Ting. 1998. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene [In Process Citation]. J. Immunol. 160:233.
36. Boothby, M., E. Gravallese, H.-C. Liou, and L. H. Glimcher. 1988. A DNA binding protein regulated by IL-4 and by differentiation in B cells. Science 242: 1559.
37. Gravallese, E. M., J. M. Darling, L. H. Glimcher, and M. Boothby. 1991. Role of lipopolysaccharide and IL-4 in control of transcription of the class II A α gene. J. Immunol. 147:2377.
38. Killar, L. M., C. A. Hatfield, S. R. Carding, M. Pan, G. E. Winterrowd, and K. Bottomly. 1989. In vivo administration of interleukin 1 elicits increased 1a antigen expression on B cells through the induction of interleukin 4. Eur. J. Immunol. 19:2205.
39. Zhou, H., H. S. Su, X. Zhang, J. Douhan III, and L. H. Glimcher. 1997. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant. J. Immunol. 158:4741.
40. Douhan, J., R. Lieberson, J. H. Knoll, H. Zhou, and L. H. Glimcher. 1997. An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator. J. Exp. Med. 185:1885.
41. Collinge, M., R. Pardi, and J. R. Bender. 1998. Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion. J. Immunol. 161:1589.
42. Ono, S. J., H.-C. Liou, R. Davidon, J. L. Strominger, and L. H. Glimcher. 1991. Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos. Proc. Natl. Acad. Sci. USA 88:4309.
43. Ono, S. J., and Z. Song. 1995. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box. J. Biol. Chem. 270:6396.
44. Brown, A. M., M. W. Linhoff, B. Stein, K. L. Wright, A. S. J. Baldwin, P. V. Basta, and J. P. Ting. 1994. Function of NF-κB/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-κB/Rel subunits. Mol. Cell. Biol. 14: 2926.
45. Wright, K. L., T. L. Moore, B. J. Vilen, A. M. Brown, and J. P.-Y. Ting. 1995. Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y. J. Biol. Chem. 270:20978.
46. Linhoff, M. W., K. L. Wright, and J. P.-Y. Ting. 1997. CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model. Mol. Cell. Biol. 17:4589.
47. Shachar, I., and R. A. Flavell. 1996. Requirement for invariant chain in B cell maturation and function. Science 274:106.
48. Gobin, S. J. P., A. Peijnenburg, V. Keijsers, and P. J. van den Elsen. 1997. Site α is crucial for two routes of IFN-γ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6:601.
49. Martin, B. K., K.-C. Chin, C. A. Skinner, J. C. Olsen, A. Dey, K. Ozato, and J. P.-Y. Ting. 1997. Induction of MHC class I expression by the MHC class II transactivator (CIITA). Immunity 6:591.
50. Dey, A., A. M. Thornton, M. Lonergan, S. M. Weissman, J. W. Chamberlain, and K. Ozato. 1992. Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues. Mol. Cell. Biol. 12:3590.